Company Filing History:
1 out of 306 
2 out of 832,891 Years Active: 2019-2022
Title: The Innovative Contributions of Ramesh Koukuntla
Introduction
Ramesh Koukuntla, an accomplished inventor based in Ames, IA, has made significant strides in the field of vector vaccines. With three patents to his name, he focuses on innovative technologies aimed at improving immunogenic compositions and vaccine development.
Latest Patents
Among his recent inventions, Koukuntla has developed two notable patents in the realm of vector vaccines. The first patent relates to EHV with inactivated UL18 and/or UL8, detailing the creation of novel equine herpesviruses (EHV) that have undergone inactivation of specific genetic components. This invention involves related expression cassettes and viral vectors designed to effectively express genes of interest, particularly sequences encoding antigens, thus facilitating the production of vaccines.
The second patent highlights his work on novel promoter sequences, expression cassettes, and vectors suitable for gene expression. Similar to his first patent, this invention aims to produce immunogenic compositions or vaccines through innovative viral vectors.
Career Highlights
Ramesh Koukuntla's career is marked by his impactful contributions to the field of veterinary medicine and virology. His extensive research and the resultant patents underline his commitment to advancing vaccine technology, particularly in how it relates to viral vectors and immunogenic responses.
Collaborations
Throughout his career, Koukuntla has collaborated with esteemed colleagues, including Robert Barry Mandell and Eric Martin Vaughn. These partnerships have fostered a dynamic exchange of ideas, significantly enriching the scope and application of his research findings.
Conclusion
Ramesh Koukuntla stands out as a prominent figure in the field of inventors focusing on vector vaccines. His patented innovations not only contribute to the scientific community but also hold promise for real-world applications in immunization and veterinary medicine. As the landscape of vaccine development continues to evolve, Koukuntla’s work will undoubtedly play a pivotal role in shaping future advancements.